Author:
Tomasello G.,Gambini D.,Petrelli F.,Azzollini J.,Arcanà C.,Ghidini M.,Peissel B.,Manoukian S.,Garrone O.
Funder
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Eli Lilly and Company
Roche
Amgen
Meso Scale Diagnostics
Reference88 articles.
1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci U S A,2001
2. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci U S A,2003
3. Breast cancer survival defined by the ER/PR/HER2 subtypes and a surrogate classification according to tumor grade and immunohistochemical biomarkers;Parise;J Cancer Epidemiol,2014
4. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer;Paterson;Cancer Res,1991
5. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy;Ross;Oncologist,1998
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献